Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 18, 2019

SELL
$62.51 - $69.0 $207,533 - $229,080
-3,320 Closed
0 $0
Q2 2019

Jul 17, 2019

BUY
$61.87 - $69.38 $205,408 - $230,341
3,320 New
3,320 $224,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Round Table Services, LLC Portfolio

Follow Round Table Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Table Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Table Services, LLC with notifications on news.